SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle's shares are fluctuating after a first-quarter earnings report that featured a revenue and earnings beat, fueled by triple-digit growth in cloud infrastructure. While bullish investors point to the company's record backlog and aggressive AI-driven data center expansion, others remain cautious due to negative free cash flow and broader macroeconomic uncertainty ahead of inflation data.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe shares are under pressure as investors weigh a surprise leadership transition against the company's fiscal Q3 results, which beat earnings and revenue expectations but featured a softer revenue outlook for the upcoming quarter.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The primary discussion centers on anticipation for consumer price index data, with many traders speculating about potential manipulation or leaks to influence the market before the release. Sentiment is divided between bearish traders expecting a major correction due to rising bond yields and oil prices, and bullish participants betting on a rally fueled by political catalysts.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is currently trending due to a sell-side downgrade from UBS, which cited concerns over a prolonged construction timeline, high cash burn, and limited customer commitments. While traders debate whether these risks are fully priced in or if the firm's regulatory approvals still offer a competitive edge, many are closely monitoring the stock's performance ahead of potential future deal announcements.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense selling pressure, recently hitting new 52-week lows amid broader concerns about consumer spending, weakening restaurant comps, and valuation adjustments by analysts. While some traders view the decline as a generational buying opportunity due to the company's dividend history and real estate holdings, others remain skeptical, citing high prices and shifting consumer preferences away from fast food.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is facing continued downward pressure as investors react to a recent analyst downgrade and ongoing concerns regarding mid-term growth, patent cliffs for semaglutide, and intensifying competition from Eli Lilly. While some traders view the current valuation as an attractive entry point, sentiment remains divided between those expecting further volatility and those maintaining a long-term bullish stance on the company's oral drug franchise.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing increased attention as traders discuss chart consolidation and speculate on future institutional adoption tied to the Onyx neobank and related infrastructure developments. While some investors view recent price fluctuations as healthy accumulation, others remain skeptical, frequently labeling the asset a pump-and-dump scheme or expressing frustration with its long-term performance.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is receiving attention following its inclusion in the Department of Energy's new Nuclear Energy Launch Pad program and ongoing discussions regarding the company's long-term commercial pipeline for data center power. While bullish traders point to these developments and potential hyperscaler partnerships as key catalysts, others remain skeptical, citing ongoing insider share sales and the company's lack of immediate commercial revenue.

ACV Auctions, Inc. provides a vibrant digital marketplace for wholesale vehicle transactions and data services, which offers transparent and accurate vehicle information to its customers. Its platform includes Digital Marketplace, Remarketing Centers, Data Services, and Data and Technology. The Digital Marketplace connects buyers and sellers of wholesale vehicles in an intuitive and efficient manner. The Remarketing Centers provide an additional channel to provide dealers and commercial partners with auction services. The Data Services platform offers insights into the condition and value of used vehicles for transactions both on and off its marketplace and helps dealers, their end consumers, and commercial partners make more informed decisions to transact with confidence and efficiency. The Data and Technology platform underpins everything it does, and powers its vehicle inspections, comprehensive vehicle intelligence reports, digital marketplace and operations automation platform. The company was founded by Joseph Neiman, Daniel Magnuszewsk, and Jack Greco in December 2014 and is headquartered in Buffalo, NY.

ACV Auctions Inc - Ordinary Shares - Class A

ACV Auctions is experiencing a significant surge in trading activity following the announcement that Copart will acquire the company for a cash payment of $10.50 per share. Traders are reacting to the buyout premium, with some expressing confidence in the deal while others debate the company's long-term growth and historical financials.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as retail traders react to soaring oil prices driven by escalating Middle East tensions and concerns over supply disruptions in the Red Sea. While many investors are expressing bullish sentiment and holding for higher levels, others are debating whether the price action is overextended and susceptible to a reversal following potential political developments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential?

Is BridgeBio Oncology Therapeutics, Inc. (BBOT) Stock a Rising Oncology Opportunity With KRAS G12C Therapy Potential...

What is HC Wainwright's Forecast for BBOT FY2026 Earnings?

BridgeBio Oncology Therapeutics, Inc (NASDAQ:BBOT - Free Report) - HC Wainwright cut their FY2026 earnings per share (EPS) estimates for shares of BridgeBio Oncology Therapeutics in a report issued...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 52-Week Low - Here's What Happened

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sets New 52-Week Low - Here's Why...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Up 4.9% - Here's What Happened

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Up 4.9% - Still a Buy...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8%  - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 5.8% - What's Next...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Large Volume Increase  - Still a Buy?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Sees Strong Trading Volume - Time to Buy...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - What's Next?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 6.8% - Time to Sell...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Hits New 12-Month Low - Here's What Happened...

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 1.3%  - Should You Sell?

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price Down 1.3% - Should You Sell...

BridgeBio Oncology (BBOT) Spotlights Next-Gen RAS Pipeline, $425M Cash Runway Into 2028

BridgeBio Oncology Therapeutics (NASDAQ:BBOT) used a presentation at Leerink Partners' Global Healthcare Conference to outline its strategy around next-generation RAS therapeutics, highlighting three...

Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.

BridgeBio Oncology Therapeutics Inc.

Bullish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	-$0.70	--	--	N/A
Q2 '26	-$0.56	-$0.71	-24.81%	MISSED
Q1 '26	-$0.51	-$0.53	-2.76%	MISSED
Q4 '25	-$0.63	-$0.49	22.60%	BEAT
Q3 '25	-$0.38	-$1.03	-169.87%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

BBOT Earnings

Upcoming Earnings: Q3 '26

Historical Earnings